Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
Molecular Therapy2012Vol. 21(3), pp. 561–569
Citations Over TimeTop 10% of 2012 papers
Hiroaki Uchida, Marco Marzulli, Kenji Nakano, William F. Goins, Janet Chan, Chang-Sook Hong, Lucia Mazzacurati, Ji Young Yoo, Amy Haseley, Hiroshi Nakashima, Hyunjung Baek, Heechung Kwon, Izumi Kumagai, Masahide Kuroki, Balveen Kaur, E. Antonio Chiocca, Paola Grandi, Justus B. Cohen, Joseph C. Glorioso
Related Papers
- → Oncolytic Virotherapy as Promising Immunotherapy Against Cancer: Mechanisms of Resistance to Oncolytic Viruses(2021)31 cited
- → Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model(2019)26 cited
- → Antiglioma Oncolytic Virotherapy: Unattainable Goal or a Success Story in the Making?(2013)7 cited
- → Treatment of Metastatic Neuroblastoma with Mesenchymal Stem Cell‐Based Oncolytic Virotherapy(2013)
- → Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer(2023)